14-day Premium Trial Subscription Try For FreeTry Free
NEW YORK, July 21, 2021 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Ardelyx, Inc. ("Ardelyx" or the "Company") (NASDAQ: ARDX).   Such investors are advised to
NEW YORK--(BUSINESS WIRE)-- #ARDX--Scott+Scott Attorneys at Law LLP Announces Investigation into Ardelyx Inc. (ARDX)

Why Ardelyx Shares Tanked Today

03:31pm, Tuesday, 20'th Jul 2021
Ardelyx (NASDAQ: ARDX) shares are trading lower after the company received an FDA letter regarding its NDA for tenapanor indicating deficiencies that preclude discussion of labeling and post-marketin
With the trading day more than halfway over, the broad markets were rallying after the carnage on Monday.
Boston, Massachusetts--(Newsfile Corp. - July 20, 2021) - Block & Leviton LLP announces that the firm is investigating whether Ardelyx, Inc. (NASDAQ: ARDX) committed securities fraud. Investors who ha
News from the FDA is not good for ARDX stock. Investor reaction has been swift and harsh, as is often the case with risky biotech stocks.
SAN DIEGO, July 20, 2021 /PRNewswire/ -- Shareholder rights law firm Johnson Fistel, LLP is investigating potential violations of the federal securities laws by Ardelyx, Inc. ("Ardelyx" or the "Compa

ARDX Fell Over 70% Pre-Market: Why It Happened

07:34am, Tuesday, 20'th Jul 2021
The stock price of Ardelyx Inc (NASDAQ: ARDX) fell by over 70% pre-market. This is why it happened.
Three months after revealing that the FDA had asked for more information to support tenapanor application for a chronic kidney disease drug, the FDA issued a letter to Ardelyx Inc (NASDAQ: ARDX) i
Atlanta, Georgia--(Newsfile Corp. - July 19, 2021) -  Holzer & Holzer, LLC is investigating whether Ardelyx, Inc. ("Ardelyx" or the "Company") (NASDAQ: ARDX) complied with federal securities laws. On
Shares in Ardelyx Inc. plummeted more than 70% in after-hours trading Monday, following the biopharmaceutical company's announcement that the Food and Drug Administration appears unlikely to approve a
FREMONT, Calif. and WALTHAM, June 7, 2021 /PRNewswire/ -- Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company focused on developing innovative first-in-class medicines to improve treatment for
Penny stocks that left the nest in 2021 To Watch Right Now The post Small-Cap & Penny Stocks To Watch In May Hitting It Big In 2021 appeared first on Penny Stocks to Buy, Picks, News and Information |

Ardelyx: Second Opportunity

08:00am, Wednesday, 19'th May 2021
Ardelyx: Second Opportunity
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE